Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Sep 11 - Sep 16
Contraindications and Precautions Do NOT use AOD-9604 if you: Are pregnant, trying to conceive, or breastfeeding (no safety data in pregnancy/lactation) Have active cancer or history of malignancy (peptide effects on existing cancer unknown) Are under 18 years of age (pediatric safety not established) Have known hypersensitivity to peptides or benzyl alcohol (in bacteriostatic water) Have severe kidney or liver disease without physician clearance Use with caution and enhanced monitoring if you have: Diabetes or glucose metabolism disorders (monitor blood sugar closely despite no expected impact) Cardiovascular disease (comprehensive cardiac evaluation recommended) Thyroid disorders (monitor thyroid function during therapy) History of migraines (may increase headache frequency in susceptible individuals) Drug Interactions Limited formal drug interaction studies exist for AOD-9604
& Staehler, B
Foundayo (orforglipron) is a once-daily weight-loss pill manufactured by Eli Lilly that received FDA approval just this past April 1, 2026
We are your neighbors
They are designed to be much more potent and longer-lasting than the GLP-1 your body produces naturally
For example, studies on 2,500 obese adults taking Mounjaro (tirzepatide) showed a reduction of 1520% in body weight
US$ 22.69
US$ 20.19
US$ 28.31
US$ 29.76
